These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33391522)

  • 1. Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism.
    Ni Y; Xu Z; Li C; Zhu Y; Liu R; Zhang F; Chang H; Li M; Sheng L; Li Z; Hou M; Chen L; You H; McManus DP; Hu W; Duan Y; Liu Y; Ji M
    Theranostics; 2021; 11(3):1079-1099. PubMed ID: 33391522
    [No Abstract]   [Full Text] [Related]  

  • 2. Schistosoma japonicum infection causes a reprogramming of glycolipid metabolism in the liver.
    Xu ZP; Chang H; Ni YY; Li C; Chen L; Hou M; Ji MJ
    Parasit Vectors; 2019 Aug; 12(1):388. PubMed ID: 31375125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
    Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
    J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
    Zhang M; Sun W; Zhou M; Tang Y
    Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.
    Chen X; Tan QQ; Tan XR; Li SJ; Zhang XX
    Cell Death Dis; 2021 Aug; 12(9):809. PubMed ID: 34446693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate-Activated Protein Kinase α1 in Male Mice.
    Chen T; Yan D; Cheng X; Ji X; Bian J; Yin W
    Endocrinology; 2018 May; 159(5):2008-2021. PubMed ID: 29474539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.
    Karunakaran D; Richards L; Geoffrion M; Barrette D; Gotfrit RJ; Harper ME; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2536-43. PubMed ID: 26427794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway.
    Liou CJ; Dai YW; Wang CL; Fang LW; Huang WC
    FASEB J; 2019 Nov; 33(11):11791-11803. PubMed ID: 31361524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 suppresses macrophage autophagy and promotes liver pathology in Schistosoma japonicum-infected mice.
    Zhu J; Zhang W; Zhang L; Xu L; Chen X; Zhou S; Xu Z; Xiao M; Bai H; Liu F; Su C
    J Cell Mol Med; 2018 Jul; 22(7):3353-3363. PubMed ID: 29566311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
    Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
    Liou CJ; Lee YK; Ting NC; Chen YL; Shen SC; Wu SJ; Huang WC
    Cells; 2019 May; 8(5):. PubMed ID: 31083505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.
    Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
    Toxicol Appl Pharmacol; 2017 Feb; 316():74-82. PubMed ID: 28038998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
    Bhatia H; Pattnaik BR; Datta M
    Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.